| 12.08 12:57 | dpa-AFX: *BD NAMES MICHAEL FELD AS PRESIDENT OF LIFE SCIENCES SEGMENT |
| 01.08 12:48 | dpa-AFX: ROUNDUP: Becton, Dickinson Boosts FY24 Ad, EPS Outlook |
| 01.08 12:47 | dpa-AFX: *BECTON DICKINSON NOW EXPECTS FY24 ADJ. EPS OF $13.05 TO $13.15 |
| 01.08 12:46 | dpa-AFX: *BECTON DICKINSON NOW EXPECTS FY24 REVENUE OF APPROX. $20.1 BLN |
| 01.08 12:45 | dpa-AFX: *BECTON DICKINSON Q3 REVENUES $4.990 BLN VS. $4.878 BLN LAST YEAR |
| 01.08 12:45 | dpa-AFX: *BECTON DICKINSON Q3 NET INCOME $487 MLN VS. $392 MLN LAST YEAR |
| 01.08 12:45 | dpa-AFX: *BECTON DICKINSON Q3 OPERATING INCOME $602 MLN VS. $549 MLN LAST YEAR |
| 01.08 12:38 | dpa-AFX: Becton, Dickinson And Company Q3 Profit Increases, Beats Estimates |
| 01.08 12:33 | dpa-AFX: *BECTON DICKINSON Q3 GAAP EPS $1.68: ADJ. EPS $3.50 |
| 23.07 22:18 | dpa-AFX: *BECTON, DICKINSON AND COMPANY (BDX) DECLARES QUARTERLY DIVIDEND OF $ 0.95, RECORD DATE 9/9/2024 |
| 03.06 12:56 | dpa-AFX: Edwards Lifesciences Stock Up With BD Deal To Buy Critical Care Product Unit For $4.2 Bln Cash |
| 03.06 12:37 | dpa-AFX: *BD TO ACQUIRE CRITICAL CARE FOR $4.2 BLN, SEES DEAL TO CLOSE BEFORE END OF CALENDAR YEAR |
| 03.06 12:37 | dpa-AFX: *BD TO ACQUIRE CRITICAL CARE; EXPECTS TO FUND ALL-CASH TRANSACTION WITH ABOUT $1 BLN OF CASH, $3.2 BLN OF NEW DEBT |
| 03.06 12:36 | dpa-AFX: *BD TO ACQUIRE CRITICAL CARE FOR $4.2 BLN, SEES DEAL IMMEDIATELY ACCRETIVE TO ALL KEY FINANCIAL MEASURES |
| 03.06 12:34 | dpa-AFX: *BD TO BUY EDWARDS LIFESCIENCES' CRITICAL CARE PRODUCT GROUP FOR $4.2 BLN IN CASH |
| 30.05 12:40 | dpa-AFX: *GOLDMAN STARTS BECTON. DICKINSON & CO, WITH 'BUY' - PRICE TARGET 274 USD |
| 30.05 12:40 | dpa-AFX: *GOLDMAN STARTET BECTON, DICKINSON & CO. MIT 'BUY' - ZIEL 274 USD |
| 02.05 12:56 | dpa-AFX: BD Lifts FY24 Earnings View In Line Or Above Market Estimates; Stock Up In Pre-market |
| 02.05 12:36 | dpa-AFX: Becton, Dickinson and Company Q2 Profit Increases, beats estimates |
| 02.05 12:36 | dpa-AFX: *BD Q2 EPS $1.85 VS $1.53 PRIOR YEAR |
|
|
